Indaptus Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.80

+0.25 (+16.13%)

As of Feb 8, 2:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,165.0% upside

Low Target $30.54

Average Target $40.77

High Target $54.50

Current Price $1.80

Current
$1.80

Target
$40.77

$30.54 $40.77 avg $54.50

Scenario Analysis

Bear Case

$30.54

1,596.7%

Low target

Base Case

$40.77

+2,165.0%

Avg target

Bull Case

$54.50

+2,927.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$46.18

-96.1% from high

52-Week Low

$30.34

+-94.1% from low

Target vs 52W High

$40.77

-11.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%